Literature DB >> 6731200

[Clinical experience of Hachimijiogan for male infertility patients].

K Miura, M Matsuhashi, A Maki, M Takanami, K Fujio, K Nakayama, M Shirai, K Ando.   

Abstract

We treated 53 patients for male infertility with TSUMURA - Hachimijiogan given as a daily dose of 7.5 g for 144 days on the average. The sperm density was improved by administration to 10 X 10(6)/ml or more in 22 patients (41.5%) and lowered to 10 X 10(6)/ml or more in only 2 patients (3.8%). The sperm motility was improved by 10% or over in 29 patients (54.7%) as compared with 5 patients (9.4%) in whom it was lowered by 10% or more. The sperm motile efficiency index ( SMEI ) was improved in 40 (75.5%) of the 53 patients. Statistically significant differences were noted in the improvement in sperm density, sperm motility and SMEI . By contrast, there was no difference in semen volume, sperm morphology or sperm agglutination between the pre- and post- treatment periods. During the period of treatment, the wives of 4 patients (7.5%) conceived children. These results suggest that TSUMURA - Hachimijiogan is effective for male infertility to a certain extent and that clinical trials on its use for male infertility may be meaningful.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6731200

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  1 in total

1.  Effects of Hachimijiogan, a Kampo powder, on epididymidis sperm characteristics in healthy male rats.

Authors:  Yuying Wang; Chiaki Murayama; Seiwa Michihara; Toru R Saito; Hisayoshi Norimoto
Journal:  Reprod Med Biol       Date:  2014-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.